Results 141 to 150 of about 114,208,131 (218)

Genetic Determinants Analysis of PB1 and PB2 Genes in H5N1 Avian Influenza Strains from Romania. [PDF]

Pathogens
Gurău MR, Bărbuceanu F, Gligor A, Șonea C, Ștefan G, Daneș D, Negru E, Fiț IN, Zsuzsa K, Hristescu DV, Vuță VB, Burlacu R, Iancu I, Herman V, Bărăităreanu S.   +14 more
europepmc   +1 more source

Detection of antibodies against avian influenza in European dairy cattle, the Netherlands, January 2026. [PDF]

Euro Surveill
Ballmann MZ, Bordes L, Bouwman KM, Engelsma MY, Venema-Kemper S, Pritz-Verschuren SB, Heutink R, Roose M, Spierenburg MA, van der Spek A, Roest HI, Germeraad EA.   +11 more
europepmc   +1 more source

CEIRR Risk Assessment Pipeline executive reports on H5N1 highly pathogenic avian influenza 2.3.4.4b, swine H1 1B.2, and H9N2 low pathogenicity avian influenza B4.7.2. [PDF]

J Virol
Centers of Excellence for Influenza Research and Response Risk Assessment Pipeline.
europepmc   +1 more source

Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history. [PDF]

Nat Commun
Ort JT, Sobel Leonard A, Li SH, Atkinson RK, Mendoza LM, Vieira MC, Gang S, Cobey S, Hensley SE.   +8 more
europepmc   +1 more source

Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada. [PDF]

J Infect Dis
Skowronski DM, Ranadheera C, Kaweski SE, Sabaiduc S, Separovic L, Makowski G, Ung J, Reyes RC, Henry B, Albert A, Clemens F, Kobasa D, Bastien N.   +12 more
europepmc   +1 more source

Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvant. [PDF]

mSphere
Riley DV, Baracco L, Das S, Tenaglia BM, Speed S, Dillen C, Hayes J, Del Veliz S, Nijhuis H, Le Sage V, Despres HW, Coughlan L, Sun W, Frieman MB, Ernst RK.   +14 more
europepmc   +1 more source

A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model. [PDF]

J Virol
Ao Z, Vendramelli R, Buyu M, Truong T, Liu D, Gao N, Ma H, Amos S, Lawrynuik P, Nyamekye M, Fowke KR, Pelka P, Shmulevitz M, Kung SKP, Kobasa D, Yao X.   +15 more
europepmc   +1 more source

Detection of H5N1-Related PB1 Sequences in a Low Pathogenic H11N2 Virus from South American Migratory Shorebirds. [PDF]

Viruses
de Araujo J, Lage Ferreira H, Fabrizio TP, Thomazelli LM, Walker D, Ometto T, Caleiro GS, Ozaki DYSR, Reis NAD, Fenner GO, Vizu FP, Brum AC, Haas ML, Finger JVG, Petry MV, Becker VD, Silva DRD, Hoffmann PHO, Royes ICL, Pinho JRR, Amgarten D, Dorlass EG, Borges ALB, Malta FM, Oliveira DBL, Greatti A, Webster RG, Webby RJ, Arns CW, Durigon EL.   +29 more
europepmc   +1 more source

Rapid Expansion of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Genotype D1.1 Virus across Flyway Regions, North America, Fall 2024. [PDF]

Emerg Infect Dis
Scotch M, Faleye TOC, Urquidez-Negrete A, Varsani A, Fan A, Justice-Allen A.   +5 more
europepmc   +1 more source

Replication Efficiency of Contemporary Highly Pathogenic Avian Influenza A(H5N1) Virus Isolates in Human Nasal Epithelium Model. [PDF]

Emerg Infect Dis
Flagg M, Winski CJ, Brackney BG, Lutterman TR, Ortiz-Morales JA, Williamson BN, de Wit E.   +6 more
europepmc   +1 more source